Abstract
Avian colibacillosis is regarded as one of the most severe bacterial diseases in the poultry industry worldwide. Due to the emerging antimicrobial resistance issue in isolated E. coli from poultry sources, the application of medicinal plants to treat colibacillosis is widely being studied due to the presence of the respective bioactive compounds. This article reviewed studies between the year 2016 to 2022 that used medicinal plants as avian colibacillosis treatment in in-vitro and in-vivo studies. The review provided insights to the readers regarding the type of plants used, the form of treatments and outcomes of previous experiments. A better understanding of the information addressed in this review article helps poultry researchers and industry to explore the potential of various medicinal plants in managing, reducing, and eliminating avian colibacillosis from poultry flocks.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
